{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:25:17Z","timestamp":1793917517781,"version":"4.8.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000096","name":"Scottish Rite Charitable Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["DGECR-2018-00315"],"award-info":[{"award-number":["DGECR-2018-00315"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN -2023-04656"],"award-info":[{"award-number":["RGPIN -2023-04656"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111150","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:51:20Z","timestamp":1786722680000},"page":"111150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dimethyl fumarate ameliorates behavioural and brain oscillatory alterations induced by prenatal valproic acid exposure in female rats"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9326-5264","authenticated-orcid":false,"given":"Olivia O.F.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0483-5286","authenticated-orcid":false,"given":"Joshua D.","family":"Manduca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7172-4392","authenticated-orcid":false,"given":"Alana Y.","family":"Coulombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5319-9370","authenticated-orcid":false,"given":"Shannon N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3561-9534","authenticated-orcid":false,"given":"Tori M.","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7653-9262","authenticated-orcid":false,"given":"Matthew R.","family":"Holahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-8950","authenticated-orcid":false,"given":"Melissa L.","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111150_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1227\/NEU.0b013e3182676b91","article-title":"Long-term recordings of local field potentials from implanted deep brain stimulation electrodes","volume":"71","author":"Abosch","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuropharm.2026.111150_bib2","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1038\/s41380-026-03490-x","article-title":"Myelin dysfunction in autism spectrum disorder: insights into core symptoms and mechanisms of brain development","volume":"31","author":"Ad\u00e8s","year":"2026","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111150_bib3","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/scan\/nsw027","article-title":"Sex differences in autism: a resting-state fMRI investigation of functional brain connectivity in males and females","volume":"11","author":"Alaerts","year":"2016","journal-title":"Soc. Cognit. Affect Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1108110","article-title":"Camouflage and masking behavior in adult autism","volume":"14","author":"Alaghband-rad","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111150_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s10571-020-01020-z","article-title":"GSK-3\u03b2 disrupts neuronal oscillatory function to inhibit learning and memory in male rats","volume":"42","author":"Albeely","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mcn.2014.01.007","article-title":"Increased BDNF expression in fetal brain in the valproic acid model of autism","volume":"59","author":"Almeida","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib7","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.neuropharm.2026.111150_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13229-024-00598-1","article-title":"The relationship between gamma-band neural oscillations and language skills in youth with autism spectrum disorder and their first-degree relatives","volume":"15","author":"Arutiunian","year":"2024","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuropharm.2026.111150_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","article-title":"Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome","volume":"25","author":"Ashwood","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.111150_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/08039488.2023.2168055","article-title":"Serum claudin-5, claudin-11, occludin, vinculin, paxillin, and beta-catenin levels in preschool children with autism spectrum disorder","volume":"77","author":"Bilgi\u00e7","year":"2023","journal-title":"Nord. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111150_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuroscience.2013.03.030","article-title":"Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder","volume":"241","author":"Bringas","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111150_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111150_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.696461","article-title":"The antidepressant-like and analgesic effects of kratom alkaloids are accompanied by changes in low frequency oscillations but not \u0394FosB accumulation","volume":"12","author":"Buckhalter","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib14","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1126\/science.1099745","article-title":"Neuronal oscillations in cortical networks","volume":"304","author":"Buzs\u00e1ki","year":"2004","journal-title":"Science."},{"key":"10.1016\/j.neuropharm.2026.111150_bib15","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1007\/s12035-024-04491-z","article-title":"Animal model of autism induced by valproic acid combined with maternal deprivation: sex-specific effects on inflammation and oxidative stress","volume":"62","author":"Campos","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10803-006-0331-7","article-title":"Sex differences in toddlers with autism spectrum disorders","volume":"37","author":"Carter","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2026.111150_bib17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/antiox14030320","article-title":"Oxidative stress indicated by nuclear transcription factor Nrf2 and glutathione status in the blood of young children with autism spectrum disorder: pilot study","volume":"14","author":"Che\u0142chowska","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuropharm.2026.111150_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/dneu.22874","article-title":"Cortical myelination in toddlers and preschoolers with autism spectrum disorder","volume":"82","author":"Chen","year":"2022","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103661","article-title":"Oxidative stress response and NRF2 signaling pathway in autism spectrum disorder","volume":"83","author":"Davinelli","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jdn.10137","article-title":"Resveratrol prevents brain edema, blood\u2013brain barrier permeability, and altered aquaporin profile in autism animal model","volume":"81","author":"Deckmann","year":"2021","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1017\/S0033291714001858","article-title":"White-matter relaxation time and myelin water fraction differences in young adults with autism","volume":"45","author":"Deoni","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2026.111150_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2022.100989","article-title":"Sex differences in the blood\u2013brain barrier: implications for mental health","volume":"65","author":"Dion-Albert","year":"2022","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/1362361315627136","article-title":"The neuroanatomy of autism spectrum disorder: An overview of structural imaging findings and their translatability to the clinical setting","volume":"21","author":"Ecker","year":"2017","journal-title":"Autism"},{"key":"10.1016\/j.neuropharm.2026.111150_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11920-018-0874-2","article-title":"Sex differences in autism spectrum disorder: a review","volume":"20","author":"Ferri","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2026.111150_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13229-016-0110-z","article-title":"Blood\u2013brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders","volume":"7","author":"Fiorentino","year":"2016","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuropharm.2026.111150_bib27","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s11682-024-00907-5","article-title":"Sex differences in the flexibility of dynamic network reconfiguration of autism spectrum disorder based on multilayer network","volume":"18","author":"Gao","year":"2024","journal-title":"Brain Imag. Behav."},{"key":"10.1016\/j.neuropharm.2026.111150_bib28","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.3390\/ijms21103576","article-title":"Prenatal exposure to valproic acid affects microglia and synaptic ultrastructure in a brain-region-specific manner in young-adult male rats: relevance to autism spectrum disorders","volume":"21","author":"G\u0105ssowska-Dobrowolska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fncel.2018.00517","article-title":"Hypomyelination and oligodendroglial alterations in a mouse model of autism spectrum disorder","volume":"12","author":"Graciarena","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib30","doi-asserted-by":"crossref","first-page":"kyaf008","DOI":"10.1093\/discim\/kyaf008","article-title":"Inflammation's impact on the interaction between oligodendrocytes and axons","volume":"4","author":"Green","year":"2025","journal-title":"Discov. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12987-023-00424-5","article-title":"The CLDN5 gene at the blood-brain barrier in health and disease","volume":"20","author":"Hashimoto","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neuropharm.2026.111150_bib32","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/hmg\/ddx167","article-title":"Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans","volume":"26","author":"Hayashi","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2026.111150_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4287711","article-title":"The beneficial role of Nrf2 in the endothelial dysfunction of atherosclerosis","volume":"2022","author":"Huang","year":"2022","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.neuropharm.2026.111150_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2022.12.001","article-title":"Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD)","volume":"108","author":"Hughes","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.111150_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/bs6040029","article-title":"Peripheral inflammatory markers contributing to comorbidities in autism","volume":"6","author":"Inga J\u00e1come","year":"2016","journal-title":"Behav. Sci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib36","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/fcp.12567","article-title":"Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system","volume":"34","author":"Ishola","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2040-2392-5-35","article-title":"Default mode network in young male adults with autism spectrum disorder: relationship with autism spectrum traits","volume":"5","author":"Jung","year":"2014","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuropharm.2026.111150_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143126","article-title":"Sex differences in the default mode network with regard to autism spectrum traits: a resting state fMRI study","volume":"10","author":"Jung","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111150_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145711001714","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"16","author":"Kataoka","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104441","article-title":"Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: relevance for susceptibility and resilience in autism","volume":"110","author":"Kazlauskas","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2026.111150_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102586","article-title":"Perceived misdiagnosis of psychiatric conditions in autistic adults","volume":"71","author":"Kentrou","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.neuropharm.2026.111150_bib42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neubiorev.2016.10.002","article-title":"Brain oscillations and connectivity in autism spectrum disorders (ASD): New approaches to methodology, measurement and modelling","volume":"71","author":"Kessler","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuropharm.2026.111150_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41398-019-0590-7","article-title":"Precocious myelination in a mouse model of autism","volume":"9","author":"Khanbabaei","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111150_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12035-014-8987-z","article-title":"MeCP2 modulates sex differences in the postsynaptic development of the valproate animal model of autism","volume":"53","author":"Kim","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib45","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jnc.12147","article-title":"Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder","volume":"124","author":"Kim","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111150_bib46","first-page":"40","article-title":"Fixel based analysis reveals atypical white matter micro- and macrostructure in adults with autism spectrum disorder: an investigation of the role of biological sex. Front. Integr","volume":"14","author":"Kirkovski","year":"2020","journal-title":"Neurosci"},{"key":"10.1016\/j.neuropharm.2026.111150_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresbull.2016.03.013","article-title":"Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats","volume":"124","author":"Kumar","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.111150_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.expneurol.2015.02.022","article-title":"Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity","volume":"266","author":"Kunze","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib49","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jfma.2018.06.017","article-title":"Valproate is protective against 6-OHDA-induced dopaminergic neurodegeneration in rodent midbrain: a potential role of BDNF up-regulation","volume":"118","author":"Lai","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2026.111150_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2017.01.019","article-title":"Developmental microglial priming in postmortem autism spectrum disorder temporal cortex","volume":"62","author":"Lee","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.111150_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059839","article-title":"Theoretical analysis of the local field potential in deep brain stimulation applications","volume":"8","author":"Lempka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111150_bib52","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1007\/s12035-020-01976-5","article-title":"Postmortem studies of neuroinflammation in autism spectrum disorder: a systematic review","volume":"57","author":"Liao","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib53","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2026.111150_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2023.104090","article-title":"Prenatally VPA exposure is likely to cause autistic-like behavior in the rats offspring via TREM2 down-regulation to affect the microglial activation and synapse alterations","volume":"99","author":"Luo","year":"2023","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s40001-026-03840-z","article-title":"Neuroinflammation and blood\u2013brain barrier dysfunction in cerebral small vessel disease: mechanisms, biomarkers, and therapeutic implications","volume":"31","author":"Luo","year":"2026","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.neuropharm.2026.111150_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2020.05.012","article-title":"Transient dose-dependent effects of ketamine on neural oscillatory activity in wistar-kyoto rats","volume":"441","author":"Manduca","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111150_bib57","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s10803-011-1356-0","article-title":"Sex differences in autism spectrum disorder: Evidence from a large sample of children and adolescents","volume":"42","author":"Mandy","year":"2012","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.neuropharm.2026.111150_bib58","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.npp.1301453","article-title":"Abnormal fear conditioning and amygdala processing in an animal model of autism","volume":"33","author":"Markram","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111150_bib59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-017-0100-y","article-title":"An overview of autism spectrum disorder, heterogeneity and treatment options","volume":"33","author":"Masi","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2026.111150_bib60","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.rasd.2013.07.003","article-title":"Comorbidity and autism: trends, topics and future directions","volume":"7","author":"Matson","year":"2013","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.neuropharm.2026.111150_bib61","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/jid.2011.46","article-title":"Suppression of VEGFR2 expression in human endothelial cells by dimethylfumarate treatment: evidence for anti-angiogenic action","volume":"131","author":"Meissner","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib62","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling","volume":"175","author":"Melancia","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib63","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.3390\/jcm11102725","article-title":"Altered blood brain barrier permeability and oxidative stress in Cntnap2 knockout rat model","volume":"11","author":"Memis","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuropharm.2026.111150_bib64","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12987-026-00818-1","article-title":"Convergent blood-brain barrier breakdown in schizophrenia and autism spectrum disorders: a systematic review of preclinical animal models","volume":"23","author":"Morente-Montilla","year":"2026","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neuropharm.2026.111150_bib65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molimm.2021.12.009","article-title":"Imbalance in pro-inflammatory and anti-inflammatory cytokines milieu in B cells of children with autism","volume":"141","author":"Nadeem","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib66","doi-asserted-by":"crossref","first-page":"e1405","DOI":"10.1542\/peds.2013-1545","article-title":"Deficits in bioenergetics and impaired immune response in granulocytes from children with autism","volume":"133","author":"Napoli","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2026.111150_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.889636","article-title":"Sex differences in autism spectrum disorder: diagnostic, neurobiological, and behavioral features","volume":"13","author":"Napolitano","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111150_bib68","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fnagi.2017.00434","article-title":"Disparate effects of lithium and a GSK-3 inhibitor on neuronal oscillatory activity in prefrontal cortex and hippocampus","volume":"9","author":"Nguyen","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00144","article-title":"Comparison of the time-dependent changes in immediate early gene labeling and spine density following abstinence from contingent or non-contingent chocolate pellet delivery","volume":"12","author":"Noye Tuplin","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib71","first-page":"1084","article-title":"New insights in the targets of action of dimethyl fumarate in endothelial cells: effects on energetic metabolism and serine synthesis in vitro and in vivo. Commun","volume":"6","author":"Oca\u00f1a","year":"2023","journal-title":"Biol"},{"key":"10.1016\/j.neuropharm.2026.111150_bib72","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbi.2011.08.007","article-title":"The role of immune dysfunction in the pathophysiology of autism","volume":"26","author":"Onore","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.111150_bib73","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41398-025-03464-7","article-title":"Sex-specific cortical networks drive social behavior differences in an autism spectrum disorder model","volume":"15","author":"Pais","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111150_bib74","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbi.2025.02.030","article-title":"The interplay between oxidative stress and inflammation supports autistic-related behaviors in Cntnap2 knockout mice","volume":"127","author":"Pangrazzi","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.111150_bib76","series-title":"The Rat Brain in Sterotaxic Coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.neuropharm.2026.111150_bib77","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41593-019-0578-x","article-title":"A myelin-related transcriptomic profile is shared by Pitt\u2013Hopkins syndrome models and human autism spectrum disorder","volume":"23","author":"Phan","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib78","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fncel.2020.00139","article-title":"G protein-coupled receptors in the mammalian blood-brain barrier","volume":"14","author":"Pluimer","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib79","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/978-1-4939-9554-7_29","article-title":"The contribution of inflammation to autism spectrum disorders: recent clinical evidence","author":"Prata","year":"2019","journal-title":"Methods Mol. Biol. 2011"},{"key":"10.1016\/j.neuropharm.2026.111150_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mcn.2016.06.004","article-title":"Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats","volume":"75","author":"Qin","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib81","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2021.688424","article-title":"On the importance of being flexible: dynamic brain networks and their potential functional significances","volume":"15","author":"Safron","year":"2022","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib83","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.111.190132","article-title":"Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway","volume":"341","author":"Scannevin","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111150_bib84","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111150_bib85","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2026.111150_bib86","first-page":"56","article-title":"Inflammation and neuro-immune dysregulations in autism spectrum disorders","volume":"11","author":"Siniscalco","year":"2018","journal-title":"Pharm. Times"},{"key":"10.1016\/j.neuropharm.2026.111150_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111442","article-title":"Peri-adolescent bupropion treatment alters adult operant responding and is associated with reduced \u0394FosB and thin spine density in the nucleus accumbens in rats","volume":"229","author":"Smith","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.111150_bib88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0009-8981(03)00119-0","article-title":"Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism","volume":"331","author":"S\u00f6\u011f\u00fct","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neuropharm.2026.111150_bib89","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/syn.21759","article-title":"Prefrontal cortex, hippocampus, and basolateral amygdala plasticity in a rat model of autism spectrum","volume":"68","author":"Sosa-D\u00edaz","year":"2014","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2026.111150_bib90","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1080\/20473869.2023.2185959","article-title":"NRF2, KEAP1 and GSK-3 levels in autism spectrum disorder: a case control study","volume":"70","author":"Subasi Turgut","year":"2024","journal-title":"Int. J. Dev. Disabil."},{"key":"10.1016\/j.neuropharm.2026.111150_bib91","article-title":"Prenatal broad-spectrum cannabidiol administration prevents an autism-like phenotype in male offspring from a maternal stress\/terbutaline rat model","volume":"40","author":"Taylor","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.111150_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039127","article-title":"Developmental trajectories of resting EEG power: an endophenotype of autism spectrum disorder","volume":"7","author":"Tierney","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111150_bib93","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12192-023-01331-2","article-title":"Oxidative stress and neuroimmune proteins in a mouse model of autism","volume":"28","author":"Uddin","year":"2023","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.neuropharm.2026.111150_bib94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tics.2009.12.002","article-title":"Neural synchrony and the development of cortical networks","volume":"14","author":"Uhlhaas","year":"2010","journal-title":"Trends Cognit. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111150_bib95","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrn2774","article-title":"Abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"Uhlhaas","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/biom13020353","article-title":"Reactive oxygen species and Nrf2 signaling, friends or foes in cancer?","volume":"13","author":"Wang","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2026.111150_bib97","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1038\/s41467-021-25487-6","article-title":"Functional and molecular characterization of a non-human primate model of autism spectrum disorder shows similarity with the human disease","volume":"12","author":"Watanabe","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111150_bib98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cpr.2016.08.001","article-title":"Effectiveness of cognitive behavioural therapy with people who have autistic spectrum disorders: a systematic review and meta-analysis","volume":"49","author":"Weston","year":"2016","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2026.111150_bib99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","article-title":"Fetal valproate syndrome and autism: additional evidence of an association","volume":"43","author":"Williams","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118949","article-title":"Cannflavin B ameliorates behavioural and neuronal systems alterations in adolescent rats exposed to prenatal valproic acid","volume":"195","author":"Williams","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111150_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111222","article-title":"Prenatal exposure to valproic acid induces sex-specific alterations in rat cortical and hippocampal neuronal structure and function in vitro","volume":"136","author":"Williams","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111150_bib102","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41398-021-01757-1","article-title":"Sex differences in neuronal systems function and behaviour: beyond a single diagnosis in autism spectrum disorders","volume":"11","author":"Williams","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111150_bib103","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1007\/s12035-016-0074-1","article-title":"Alleviation of N-methyl-d-aspartate receptor-dependent long-term depression via regulation of the glycogen synthase kinase-3\u03b2 pathway in the amygdala of a valproic acid-induced animal model of autism","volume":"54","author":"Wu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib104","doi-asserted-by":"crossref","first-page":"82390","DOI":"10.18632\/oncotarget.19326","article-title":"Immunological cytokine profiling identifies TNF-\u03b1 as a key molecule dysregulated in autistic children","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2026.111150_bib105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00109-019-01761-5","article-title":"Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis","volume":"97","author":"Yadav","year":"2019","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111150_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107844","article-title":"Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviating inflammation, oxidative stress, and ferroptosis via NRF2\/ARE\/NF-\u03baB signal pathway","volume":"98","author":"Yan","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib107","first-page":"364","article-title":"Default mode hypoconnectivity underlies a sex-related autism spectrum","volume":"1","author":"Ypma","year":"2016","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.neuropharm.2026.111150_bib108","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neulet.2017.03.001","article-title":"Protective effects of angiopoietin-like 4 on the blood-brain barrier in acute ischemic stroke treated with thrombolysis in mice","volume":"645","author":"Zhang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111150_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103473","article-title":"Microglial Nrf2-mediated lipid and iron metabolism reprogramming promotes remyelination during white matter ischemia","volume":"79","author":"Zhang","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib110","article-title":"Neuroinflammatory mechanisms and pharmacological advances in autism spectrum disorder: from inflammatory pathways to targeted interventions","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111150_bib111","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41398-019-0608-1","article-title":"Maternal valproic acid exposure leads to neurogenesis defects and autism-like behaviors in non-human primates","volume":"9","author":"Zhao","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111150_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2025.121128","article-title":"Alterations in brain iron and myelination in children with ASD: a susceptibility source separation imaging study","volume":"310","author":"Zhou","year":"2025","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2026.111150_bib113","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fnhum.2013.00609","article-title":"Altered neural connectivity in excitatory and inhibitory cortical circuits in autism","volume":"7","author":"Zikopoulos","year":"2013","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111150_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2026.1787670","article-title":"The relationship between functional brain connectivity and neuroinflammatory processes-new insights into the pathomechanisms of ASD","volume":"20","author":"Zwierko","year":"2026","journal-title":"Front. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:50:17Z","timestamp":1793915417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":114,"alternative-id":["S0028390826003254"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111150","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dimethyl fumarate ameliorates behavioural and brain oscillatory alterations induced by prenatal valproic acid exposure in female rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111150"}}